Our study demonstrates that systemically administered resveratrol efficiently reduces the frequency and severity of thyroid cancer-related lesions in DEN/MNU/DHPN-induced carcinogenic model through inhibiting proliferation and suppressing NF-κB mediated inflammatory reaction. The gene discussed is NFKB1; the disease is thyroid cancer.